Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
Total Valuation
IDEAYA Biosciences has a market cap or net worth of $1.47B. The enterprise value is $1.59B.
Market Cap$1.47B
Enterprise Value$1.59B
Share Statistics
IDEAYA Biosciences has 87.54M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding87.54M
Owned by Insiders0.89%
Owned by Instutions28.74%
Financial Efficiency
IDEAYA Biosciences’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -30.31%.
Return on Equity (ROE)-25.91%
Return on Assets (ROA)-24.42%
Return on Invested Capital (ROIC)-30.31%
Return on Capital Employed (ROCE)-30.33%
Revenue Per Employee$53,435.115
Profits Per Employee-$2,095,244.275
Employee Count131
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of IDEAYA Biosciences is -7.65. IDEAYA Biosciences’s PEG ratio is -0.11.
PE Ratio-7.65
PS Ratio299.88
PB Ratio1.98
Price to Fair Value1.98
Price to FCF-8.35
Price to Operating Cash Flow-8.48
PEG Ratio-0.11
Income Statement
In the last 12 months, IDEAYA Biosciences had revenue of $7.00M and earned -$274.48M in profits. Earnings per share was -$3.41.
Revenue$7.00M
Gross Profit$4.82M
Operating Income-$326.98M
Pretax Income-$274.48M
Net Income-$274.48M
EBITDA-325.09M
Earnings Per Share (EPS)-3.41
Cash Flow
In the last 12 months, operating cash flow was -$247.58M and capital expenditures -$3.86M, giving a free cash flow of -$251.44M billion.
Operating Cash Flow-$247.58M
Free Cash Flow-$251.44M
Free Cash Flow per Share-$2.87
Dividends & Yields
IDEAYA Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-11.98%
Earnings Yield-13.08%
Stock Price Statistics
Beta1.44
52-Week Price Change-58.44%
50-Day Moving Average19.00
200-Day Moving Average28.63
Relative Strength Index (RSI)48.30
Average Volume (3m)1.34M
Important Dates
IDEAYA Biosciences upcoming earnings date is May 13, 2025, Before Open.
Last Earnings DateFeb 13, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
IDEAYA Biosciences as a current ratio of 14.97, with Debt / Equity ratio of 0.02
Current Ratio14.97
Quick Ratio14.97
Debt to Market Cap<0.01
Net Debt to EBITDA0.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, IDEAYA Biosciences has paid -$1.08M in taxes.
Income Tax-$1.08M
Effective Tax Rate0.00%
Enterprise Valuation
IDEAYA Biosciences EV to EBITDA ratio is -6.22, with an EV/FCF ratio of -8.09.
EV to Sales290.56
EV to EBITDA-6.22
EV to Free Cash Flow-8.09
EV to Operating Cash Flow-8.22
Balance Sheet
IDEAYA Biosciences has $676.32M in cash and marketable securities with $19.17M in debt, giving a net cash position of -$657.15M billion.
Cash & Marketable Securities$676.32M
Total Debt$19.17M
Net Cash-$657.15M
Net Cash Per Share-$7.51
Tangible Book Value Per Share$12.97
Margins
Gross margin is 100.00%, with operating margin of -4671.07%, and net profit margin of -3921.10%.
Gross Margin100.00%
Operating Margin-4671.07%
Pretax Margin-3921.10%
Net Profit Margin-3921.10%
EBITDA Margin-4671.07%
EBIT Margin-4671.07%
Analyst Forecast
The average price target for IDEAYA Biosciences is $55.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$55.29
Price Target Upside223.14%
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast-70.07%
EPS Growth Forecast-67.97%